Cyclohexanol, 5-methyl-2-(1-methylethenyl)-, [1R-(1α,2β,5α)]-, hydroformylation products (91672-99-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Acetic acid, reaction products with (1α,2β,4β)-1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)cyclohexane and formaldehyde
- 1-Naphthalenepropanol, α-ethenyldecahydro-2-hydroxy-α,2,5,5,8a-pentamethyl-, [1R-[1α(R*),2β,4aβ,8aα]]-, oxidized
- (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
- ()(1α,2β,5β)-5-methyl-2-(1-methylethyl)cyclohexyl salicylate
- ()-(1α,2β,5α)-2-(isopropyl)-5-methylcyclohexyl benzoate
- Silicic acid (H4SiO4), mixed benzyl and (1α,2β,5α)-()-5-methyl-2-(1-methylethyl)cyclohexyl esters
- (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
- l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-5(or 12)-methyl-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocinium iodide
- 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
- 3-Cyclohexene-1-methanol, α,α,4-trimethyl-, hydroformylation products
- Naphthalene, 1,2,3,5,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethenyl)-, [1R-(1α,7β,8aα)]-, acetylated
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
- l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- (1α,2β,5α)-4,5-dimethyl-2-(2-methylpropen-2-yl)cyclohex-3-ene-1-carbaldehyde
- 5-Heptenoic acid, 7-[3,5-dihydroxy-2-[2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-, [1R-[1α(Z),2β(E),3α,5α]]-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
- [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
- 5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
- 5-oxo-L-proline, compound with [2R-[2α,6α(S*)]]-2-[6-(β-hydroxyphenethyl)-1-methyl-2-piperidyl]acetophenone (1:1)